Certain New Chemicals or Significant New Uses; Statements of Findings for May 2024, 60419-60420 [2024-16362]

Download as PDF Federal Register / Vol. 89, No. 143 / Thursday, July 25, 2024 / Notices accordance with Rules 211, 214, or 206 of the Commission’s Regulations (18 CFR 385.211, 385.214, or 385.206) on or before 5:00 p.m. Eastern time on the specified comment date. Protests may be considered, but intervention is necessary to become a party to the proceeding. eFiling is encouraged. More detailed information relating to filing requirements, interventions, protests, service, and qualifying facilities filings can be found at: https://www.ferc.gov/ docs-filing/efiling/filing-req.pdf. For other information, call (866) 208–3676 (toll free). For TTY, call (202) 502–8659. The Commission’s Office of Public Participation (OPP) supports meaningful public engagement and participation in Commission proceedings. OPP can help members of the public, including landowners, environmental justice communities, Tribal members and others, access publicly available information and navigate Commission processes. For public inquiries and assistance with making filings such as interventions, comments, or requests for rehearing, the public is encouraged to contact OPP at (202) 502–6595 or OPP@ ferc.gov. Dated: July 19, 2024. Debbie-Anne A. Reese, Acting Secretary. [FR Doc. 2024–16384 Filed 7–24–24; 8:45 am] BILLING CODE 6717–01–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPP–2023–0445; FRL–11370–04– OCSPP] Pesticides; White Paper; Framework for Interagency Collaboration To Review Potential Antibacterial and Antifungal Resistance Risks Associated With Pesticide Use; Notice of Availability and Request for Comment; Extension of Comment Period Environmental Protection Agency (EPA). ACTION: Notice; extension of comment period. AGENCY: In the Federal Register of July 2, 2024, EPA announced the availability of and solicited public comment on a framework for expanding interagency collaboration to improve the communication and knowledge base within the federal family to fully consider potential adverse impact of pesticides on efficacy of human and animal drugs. In particular, the use of antifungal and antibacterial pesticides, ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:41 Jul 24, 2024 Jkt 262001 60419 that can potentially lead to resistance in human and animal pathogens and may compromise the effectiveness of medically important antibacterial and antifungal drugs. This document extends the comment period, which was scheduled to end on August 1, 2024, for 14 days. DATES: The comment period for the document published on July 2, 2024, at 89 FR 54819 (FRL–11370–03–OCSPP) is extended. Comments must be received on or before August 15, 2024. ADDRESSES: Submit your comments, identified by ID number EPA–HQ–OPP– 2023–0445, online at https:// www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting and visiting the docket, along with more information about dockets generally, is available at https://www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: Susan Jennings, Immediate Office (7501M), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (706) 355–8574; email address: jennings.susan@epa.gov. SUPPLEMENTARY INFORMATION: To give stakeholders additional time to review materials and prepare comments, EPA is hereby extending the comment period established in the Federal Register document of July 2, 2024, at 89 FR 54819 (FRL–11370–03–OCSPP) for 14 days, from August 1, 2024, to August 15, 2024. More information on the action can be found in the Federal Register of July 2, 2024. Authority:7 U.S.C. 136 et seq. ACTION: Dated: July 22, 2024. Michal Freedhoff, Assistant Administrator, Office of Chemical Safety and Pollution Prevention. Certain New Chemicals or Significant New Uses; Statements of Findings for May 2024 [FR Doc. 2024–16373 Filed 7–24–24; 8:45 am] BILLING CODE 6560–50–P Notice of final order on petition. The Environmental Protection Agency (EPA) Administrator signed an order dated May 24, 2024 granting a petition dated October 27, 2023 from People Concerned About Chemical Safety (PCACS) and Earthjustice. The petition requested that the EPA object to a Clean Air Act (CAA) title V operating permit issued by the West Virginia Department of Environmental Protection’s Division of Air Quality (WVDEP) to Union Carbide Institute Facility for its Logistics Unit and the Catalyst Plant located in Kanawha County, West Virginia. FOR FURTHER INFORMATION CONTACT: Joseph Whapham, EPA Region 3, (215) 814–2160, Whapham.Joseph@epa.gov. The final order and petition are available electronically at: www.epa.gov/title-v-operating-permits/ title-v-petition-database. SUPPLEMENTARY INFORMATION: The EPA received a petition from PCACS and Earthjustice dated October 27, 2023, requesting that the EPA object to the issuance of operating permit No. R30– 03900005–2023, issued by WVDEP to Union Carbide Institute Facility in Kanawha County, West Virginia. On May 24, 2024, the EPA Administrator issued an order granting, the petition. The order itself explains the basis for the EPA’s decision. SUMMARY: Cristina Fernández, Division Director, Region III. [FR Doc. 2024–16355 Filed 7–24–24; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPPT–2024–0159; FRL–11684– 05–OCSPP] Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA submissions when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) SUMMARY: ENVIRONMENTAL PROTECTION AGENCY [FRL–12059–01–R3] Clean Air Act Operating Permit Program; Order on Petition for Objection to State Operating Permit for Union Carbide Corporation, Union Carbide Institute Facility Environmental Protection Agency (EPA). AGENCY: PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\25JYN1.SGM 25JYN1 60420 Federal Register / Vol. 89, No. 143 / Thursday, July 25, 2024 / Notices submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from May 1, 2024, to May 31, 2024. ADDRESSES: The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2024–0159, is available online at https:// www.regulations.gov or in-person at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For technical information contact: Rebecca Edelstein, New Chemical Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–1667 email address: edelstein.rebecca@ epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUPPLEMENTARY INFORMATION: risk of injury to health or the environment. Among those potential findings is that the chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment per TSCA Section 5(a)(3)(C). TSCA section 5(g) requires EPA to publish in the Federal Register a statement of its findings after its review of a submission under TSCA section 5(a) when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to PMNs, MCANs, and SNUNs submitted to EPA under TSCA section 5. Anyone who plans to manufacture (which includes import) a new chemical substance for a non-exempt commercial purpose and any manufacturer or processor wishing to engage in a use of a chemical substance designated by EPA as a significant new use must submit a notice to EPA at least 90 days before commencing manufacture of the new chemical substance or before engaging in the significant new use. The submitter of a notice to EPA for which EPA has made a finding of ‘‘not likely to present an unreasonable risk of injury to health or the environment’’ may commence manufacture of the chemical substance or manufacture or processing for the significant new use notwithstanding any remaining portion of the applicable review period. I. Executive Summary II. Statements of Findings Under TSCA Section 5(a)(3)(C) In this unit, EPA provides the following information (to the extent that such information is not claimed as Confidential Business Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this period, EPA has made findings under TSCA section 5(a)(3)(C) that the new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment: The following list provides the EPA case number assigned to the TSCA section 5(a) submission and the chemical identity (generic name if the specific name is claimed as CBI). • P–21–0181, 1,3Benzenedicarboxamide, N1,N3bis(carbomonocyclic)-5[[(carbomonocyclic)amino]sulfonyl](Generic Name). ddrumheller on DSK120RN23PROD with NOTICES1 A. Does this action apply to me? This action provides information that is directed to the public in general. B. What action is the Agency taking? This document lists the statements of findings made by EPA after review of submissions under TSCA section 5(a) that certain new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment. This document presents statements of findings made by EPA during the reporting period. C. What is the Agency’s authority for taking this action? TSCA section 5(a)(3) requires EPA to review a submission under TSCA section 5(a) and make one of several specific findings pertaining to whether the substance may present unreasonable VerDate Sep<11>2014 19:41 Jul 24, 2024 Jkt 262001 D. Does this action have any incremental economic impacts or paperwork burdens? No. PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 • P–22–0046, Fibroins; CASRN: 9007–76–5. • P–22–0166, Dicarboxylic acid, calcium salt (Generic Name). • P–23–0170, Ethanaminium, 2-[3(2,5-dioxo-1-heteromonocyclic) propoxy]-N,N,N-trimethyl-, monopolyisobutylene derivs., Me ethanedioate (Generic Name). • P–23–0187, Substituted benzenedicarboxylic acid, sodium salt, polymer with benzenedicarboxylic acids and 1,2-ethanediol (Generic Name). To access EPA’s decision document describing the basis of the ‘‘not likely to present an unreasonable risk’’ finding made by EPA under TSCA section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/ reviewing-new-chemicals-under-toxicsubstances-control-act-tsca/chemicalsdetermined-not-likely. Authority: 15 U.S.C. 2601 et seq. Dated: July 19, 2024. Shari Z. Barash, Director, New Chemicals Division, Office of Pollution Prevention and Toxics. [FR Doc. 2024–16362 Filed 7–24–24; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPPT- 2023–0601; FRL–11581– 03–OCSPP] Proposed High-Priority Substance Designations Under the Toxic Substances Control Act (TSCA); Notice of Availability Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: Under the Toxic Substances Control Act (TSCA) and related implementing regulations, the Environmental Protection Agency (EPA or Agency) is proposing to designate acetaldehyde (CASRN 75–07–0), acrylonitrile (CASRN 107–13–1), benzenamine (CASRN 62–53–3), vinyl chloride (CASRN 75–01–4), and 4,4methylene bis(2-chloroaniline) (MBOCA) (CASRN 101–14–4) as HighPriority Substances for risk evaluation. EPA is providing a 90-day comment period, during which interested persons may submit comments on the proposed designations of these chemicals as HighPriority Substances for risk evaluation. DATES: Comments must be received on or before October 23, 2024. ADDRESSES: Submit your comments, identified by docket identification (ID) number, through https:// www.regulations.gov. Follow the online SUMMARY: E:\FR\FM\25JYN1.SGM 25JYN1

Agencies

ENVIRONMENTAL PROTECTION AGENCY

[Federal Register Volume 89, Number 143 (Thursday, July 25, 2024)]
[Notices]
[Pages 60419-60420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-16362]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2024-0159; FRL-11684-05-OCSPP]


Certain New Chemicals or Significant New Uses; Statements of 
Findings for May 2024

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to 
publish in the Federal Register a statement of its findings after its 
review of certain TSCA submissions when EPA makes a finding that a new 
chemical substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment. Such 
statements apply to premanufacture notices (PMNs), microbial commercial 
activity notices (MCANs), and significant new use notices (SNUNs)

[[Page 60420]]

submitted to EPA under TSCA. This document presents statements of 
findings made by EPA on such submissions during the period from May 1, 
2024, to May 31, 2024.

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPPT-2024-0159, is available online 
at https://www.regulations.gov or in-person at the Office of Pollution 
Prevention and Toxics Docket (OPPT Docket), Environmental Protection 
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., 
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading 
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, 
excluding legal holidays. The telephone number for the Public Reading 
Room is (202) 566-1744, and the telephone number for the OPPT Docket is 
(202) 566-0280. For the latest status information on EPA/DC services 
and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: 
    For technical information contact: Rebecca Edelstein, New Chemical 
Division (7405M), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460-0001; telephone number: (202) 564-1667 email address: 
[email protected].
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. Executive Summary

A. Does this action apply to me?

    This action provides information that is directed to the public in 
general.

B. What action is the Agency taking?

    This document lists the statements of findings made by EPA after 
review of submissions under TSCA section 5(a) that certain new chemical 
substances or significant new uses are not likely to present an 
unreasonable risk of injury to health or the environment. This document 
presents statements of findings made by EPA during the reporting 
period.

C. What is the Agency's authority for taking this action?

    TSCA section 5(a)(3) requires EPA to review a submission under TSCA 
section 5(a) and make one of several specific findings pertaining to 
whether the substance may present unreasonable risk of injury to health 
or the environment. Among those potential findings is that the chemical 
substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment per TSCA 
Section 5(a)(3)(C).
    TSCA section 5(g) requires EPA to publish in the Federal Register a 
statement of its findings after its review of a submission under TSCA 
section 5(a) when EPA makes a finding that a new chemical substance or 
significant new use is not likely to present an unreasonable risk of 
injury to health or the environment. Such statements apply to PMNs, 
MCANs, and SNUNs submitted to EPA under TSCA section 5.
    Anyone who plans to manufacture (which includes import) a new 
chemical substance for a non-exempt commercial purpose and any 
manufacturer or processor wishing to engage in a use of a chemical 
substance designated by EPA as a significant new use must submit a 
notice to EPA at least 90 days before commencing manufacture of the new 
chemical substance or before engaging in the significant new use.
    The submitter of a notice to EPA for which EPA has made a finding 
of ``not likely to present an unreasonable risk of injury to health or 
the environment'' may commence manufacture of the chemical substance or 
manufacture or processing for the significant new use notwithstanding 
any remaining portion of the applicable review period.

D. Does this action have any incremental economic impacts or paperwork 
burdens?

    No.

II. Statements of Findings Under TSCA Section 5(a)(3)(C)

    In this unit, EPA provides the following information (to the extent 
that such information is not claimed as Confidential Business 
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this 
period, EPA has made findings under TSCA section 5(a)(3)(C) that the 
new chemical substances or significant new uses are not likely to 
present an unreasonable risk of injury to health or the environment:
    The following list provides the EPA case number assigned to the 
TSCA section 5(a) submission and the chemical identity (generic name if 
the specific name is claimed as CBI).
     P-21-0181, 1,3-Benzenedicarboxamide, N1,N3-
bis(carbomonocyclic)-5-[[(carbomonocyclic)amino]sulfonyl]- (Generic 
Name).
     P-22-0046, Fibroins; CASRN: 9007-76-5.
     P-22-0166, Dicarboxylic acid, calcium salt (Generic Name).
     P-23-0170, Ethanaminium, 2-[3-(2,5-dioxo-1-
heteromonocyclic) propoxy]-N,N,N-trimethyl-, monopolyisobutylene 
derivs., Me ethanedioate (Generic Name).
     P-23-0187, Substituted benzenedicarboxylic acid, sodium 
salt, polymer with benzenedicarboxylic acids and 1,2-ethanediol 
(Generic Name).
    To access EPA's decision document describing the basis of the ``not 
likely to present an unreasonable risk'' finding made by EPA under TSCA 
section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/chemicals-determined-not-likely.
    Authority: 15 U.S.C. 2601 et seq.

    Dated: July 19, 2024.
Shari Z. Barash,
Director, New Chemicals Division, Office of Pollution Prevention and 
Toxics.
[FR Doc. 2024-16362 Filed 7-24-24; 8:45 am]
BILLING CODE 6560-50-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.